Routine: IBDEI1K2

IBDEI1K2 ; ; 01-FEB-2022

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022

 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.3,25214,1,2,0)

 ;;=2^96376

 ;;^UTILITY(U,$J,358.3,25214,1,3,0)

 ;;=3^Tx/Pro/Dx Inj,ea addl sequential IVP of Same Drug-Add-on

 ;;^UTILITY(U,$J,358.3,25215,0)

 ;;=J2680^^91^1143^5^^^^1

 ;;^UTILITY(U,$J,358.3,25215,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,25215,1,2,0)

 ;;=2^J2680

 ;;^UTILITY(U,$J,358.3,25215,1,3,0)

 ;;=3^Fluphenazine Decanoate up to 25mg

 ;;^UTILITY(U,$J,358.3,25216,0)

 ;;=J1631^^91^1143^6^^^^1

 ;;^UTILITY(U,$J,358.3,25216,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,25216,1,2,0)

 ;;=2^J1631

 ;;^UTILITY(U,$J,358.3,25216,1,3,0)

 ;;=3^Haloperidol Decanoate per 50mg

 ;;^UTILITY(U,$J,358.3,25217,0)

 ;;=J2315^^91^1143^7^^^^1

 ;;^UTILITY(U,$J,358.3,25217,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,25217,1,2,0)

 ;;=2^J2315

 ;;^UTILITY(U,$J,358.3,25217,1,3,0)

 ;;=3^Naltrexone,Depot Form 1mg

 ;;^UTILITY(U,$J,358.3,25218,0)

 ;;=J2426^^91^1143^9^^^^1

 ;;^UTILITY(U,$J,358.3,25218,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,25218,1,2,0)

 ;;=2^J2426

 ;;^UTILITY(U,$J,358.3,25218,1,3,0)

 ;;=3^Paliperidone Palmitate Extend Release per 1mg

 ;;^UTILITY(U,$J,358.3,25219,0)

 ;;=J2794^^91^1143^10^^^^1

 ;;^UTILITY(U,$J,358.3,25219,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,25219,1,2,0)

 ;;=2^J2794

 ;;^UTILITY(U,$J,358.3,25219,1,3,0)

 ;;=3^Risperidone Long Act per 0.5mg

 ;;^UTILITY(U,$J,358.3,25220,0)

 ;;=J2315^^91^1143^11^^^^1

 ;;^UTILITY(U,$J,358.3,25220,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,25220,1,2,0)

 ;;=2^J2315

 ;;^UTILITY(U,$J,358.3,25220,1,3,0)

 ;;=3^Vivitrol 1mg

 ;;^UTILITY(U,$J,358.3,25221,0)

 ;;=J0401^^91^1143^1^^^^1

 ;;^UTILITY(U,$J,358.3,25221,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,25221,1,2,0)

 ;;=2^J0401

 ;;^UTILITY(U,$J,358.3,25221,1,3,0)

 ;;=3^Aripiprazole Ext Rel 1mg

 ;;^UTILITY(U,$J,358.3,25222,0)

 ;;=J2358^^91^1143^8^^^^1

 ;;^UTILITY(U,$J,358.3,25222,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,25222,1,2,0)

 ;;=2^J2358

 ;;^UTILITY(U,$J,358.3,25222,1,3,0)

 ;;=3^Olanzapine,Long-Acting 1mg

 ;;^UTILITY(U,$J,358.3,25223,0)

 ;;=J1943^^91^1143^2^^^^1

 ;;^UTILITY(U,$J,358.3,25223,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,25223,1,2,0)

 ;;=2^J1943

 ;;^UTILITY(U,$J,358.3,25223,1,3,0)

 ;;=3^Aristada Initio 1mg

 ;;^UTILITY(U,$J,358.3,25224,0)

 ;;=Q9991^^91^1143^3^^^^1

 ;;^UTILITY(U,$J,358.3,25224,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,25224,1,2,0)

 ;;=2^Q9991

 ;;^UTILITY(U,$J,358.3,25224,1,3,0)

 ;;=3^Buprenorphine Ext-Release (Sublocade),up to 100mg

 ;;^UTILITY(U,$J,358.3,25225,0)

 ;;=Q9992^^91^1143^4^^^^1

 ;;^UTILITY(U,$J,358.3,25225,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,25225,1,2,0)

 ;;=2^Q9992

 ;;^UTILITY(U,$J,358.3,25225,1,3,0)

 ;;=3^Buprenorphine Ext-Release (Sublocade) > 100mg

 ;;^UTILITY(U,$J,358.3,25226,0)

 ;;=96156^^91^1144^1^^^^1

 ;;^UTILITY(U,$J,358.3,25226,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,25226,1,2,0)

 ;;=2^96156

 ;;^UTILITY(U,$J,358.3,25226,1,3,0)

 ;;=3^Hlth/Behav,Assess/Reassess,Ea 15 min

 ;;^UTILITY(U,$J,358.3,25227,0)

 ;;=96158^^91^1144^2^^^^1

 ;;^UTILITY(U,$J,358.3,25227,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,25227,1,2,0)

 ;;=2^96158

 ;;^UTILITY(U,$J,358.3,25227,1,3,0)

 ;;=3^Hlth/Behav Interv,Indiv,Init 30 min

 ;;^UTILITY(U,$J,358.3,25228,0)

 ;;=96159^^91^1144^3^^^^1

 ;;^UTILITY(U,$J,358.3,25228,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,25228,1,2,0)

 ;;=2^96159

 ;;^UTILITY(U,$J,358.3,25228,1,3,0)

 ;;=3^Hlth/Behav Interv,Indiv,Ea Addl 15 min

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1K2   3786     printed  Feb 18, 2025@23:36:36                                                                                                                                                                                                    Page 2

IBDEI1K2  ; ; 01-FEB-2022

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022

 +2        if 'DIFQR(358.3)

               QUIT

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT

 +1       ;;^UTILITY(U,$J,358.3,25214,1,2,0)

 +2       ;;=2^96376

 +3       ;;^UTILITY(U,$J,358.3,25214,1,3,0)

 +4       ;;=3^Tx/Pro/Dx Inj,ea addl sequential IVP of Same Drug-Add-on

 +5       ;;^UTILITY(U,$J,358.3,25215,0)

 +6       ;;=J2680^^91^1143^5^^^^1

 +7       ;;^UTILITY(U,$J,358.3,25215,1,0)

 +8       ;;=^358.31IA^3^2

 +9       ;;^UTILITY(U,$J,358.3,25215,1,2,0)

 +10      ;;=2^J2680

 +11      ;;^UTILITY(U,$J,358.3,25215,1,3,0)

 +12      ;;=3^Fluphenazine Decanoate up to 25mg

 +13      ;;^UTILITY(U,$J,358.3,25216,0)

 +14      ;;=J1631^^91^1143^6^^^^1

 +15      ;;^UTILITY(U,$J,358.3,25216,1,0)

 +16      ;;=^358.31IA^3^2

 +17      ;;^UTILITY(U,$J,358.3,25216,1,2,0)

 +18      ;;=2^J1631

 +19      ;;^UTILITY(U,$J,358.3,25216,1,3,0)

 +20      ;;=3^Haloperidol Decanoate per 50mg

 +21      ;;^UTILITY(U,$J,358.3,25217,0)

 +22      ;;=J2315^^91^1143^7^^^^1

 +23      ;;^UTILITY(U,$J,358.3,25217,1,0)

 +24      ;;=^358.31IA^3^2

 +25      ;;^UTILITY(U,$J,358.3,25217,1,2,0)

 +26      ;;=2^J2315

 +27      ;;^UTILITY(U,$J,358.3,25217,1,3,0)

 +28      ;;=3^Naltrexone,Depot Form 1mg

 +29      ;;^UTILITY(U,$J,358.3,25218,0)

 +30      ;;=J2426^^91^1143^9^^^^1

 +31      ;;^UTILITY(U,$J,358.3,25218,1,0)

 +32      ;;=^358.31IA^3^2

 +33      ;;^UTILITY(U,$J,358.3,25218,1,2,0)

 +34      ;;=2^J2426

 +35      ;;^UTILITY(U,$J,358.3,25218,1,3,0)

 +36      ;;=3^Paliperidone Palmitate Extend Release per 1mg

 +37      ;;^UTILITY(U,$J,358.3,25219,0)

 +38      ;;=J2794^^91^1143^10^^^^1

 +39      ;;^UTILITY(U,$J,358.3,25219,1,0)

 +40      ;;=^358.31IA^3^2

 +41      ;;^UTILITY(U,$J,358.3,25219,1,2,0)

 +42      ;;=2^J2794

 +43      ;;^UTILITY(U,$J,358.3,25219,1,3,0)

 +44      ;;=3^Risperidone Long Act per 0.5mg

 +45      ;;^UTILITY(U,$J,358.3,25220,0)

 +46      ;;=J2315^^91^1143^11^^^^1

 +47      ;;^UTILITY(U,$J,358.3,25220,1,0)

 +48      ;;=^358.31IA^3^2

 +49      ;;^UTILITY(U,$J,358.3,25220,1,2,0)

 +50      ;;=2^J2315

 +51      ;;^UTILITY(U,$J,358.3,25220,1,3,0)

 +52      ;;=3^Vivitrol 1mg

 +53      ;;^UTILITY(U,$J,358.3,25221,0)

 +54      ;;=J0401^^91^1143^1^^^^1

 +55      ;;^UTILITY(U,$J,358.3,25221,1,0)

 +56      ;;=^358.31IA^3^2

 +57      ;;^UTILITY(U,$J,358.3,25221,1,2,0)

 +58      ;;=2^J0401

 +59      ;;^UTILITY(U,$J,358.3,25221,1,3,0)

 +60      ;;=3^Aripiprazole Ext Rel 1mg

 +61      ;;^UTILITY(U,$J,358.3,25222,0)

 +62      ;;=J2358^^91^1143^8^^^^1

 +63      ;;^UTILITY(U,$J,358.3,25222,1,0)

 +64      ;;=^358.31IA^3^2

 +65      ;;^UTILITY(U,$J,358.3,25222,1,2,0)

 +66      ;;=2^J2358

 +67      ;;^UTILITY(U,$J,358.3,25222,1,3,0)

 +68      ;;=3^Olanzapine,Long-Acting 1mg

 +69      ;;^UTILITY(U,$J,358.3,25223,0)

 +70      ;;=J1943^^91^1143^2^^^^1

 +71      ;;^UTILITY(U,$J,358.3,25223,1,0)

 +72      ;;=^358.31IA^3^2

 +73      ;;^UTILITY(U,$J,358.3,25223,1,2,0)

 +74      ;;=2^J1943

 +75      ;;^UTILITY(U,$J,358.3,25223,1,3,0)

 +76      ;;=3^Aristada Initio 1mg

 +77      ;;^UTILITY(U,$J,358.3,25224,0)

 +78      ;;=Q9991^^91^1143^3^^^^1

 +79      ;;^UTILITY(U,$J,358.3,25224,1,0)

 +80      ;;=^358.31IA^3^2

 +81      ;;^UTILITY(U,$J,358.3,25224,1,2,0)

 +82      ;;=2^Q9991

 +83      ;;^UTILITY(U,$J,358.3,25224,1,3,0)

 +84      ;;=3^Buprenorphine Ext-Release (Sublocade),up to 100mg

 +85      ;;^UTILITY(U,$J,358.3,25225,0)

 +86      ;;=Q9992^^91^1143^4^^^^1

 +87      ;;^UTILITY(U,$J,358.3,25225,1,0)

 +88      ;;=^358.31IA^3^2

 +89      ;;^UTILITY(U,$J,358.3,25225,1,2,0)

 +90      ;;=2^Q9992

 +91      ;;^UTILITY(U,$J,358.3,25225,1,3,0)

 +92      ;;=3^Buprenorphine Ext-Release (Sublocade) > 100mg

 +93      ;;^UTILITY(U,$J,358.3,25226,0)

 +94      ;;=96156^^91^1144^1^^^^1

 +95      ;;^UTILITY(U,$J,358.3,25226,1,0)

 +96      ;;=^358.31IA^3^2

 +97      ;;^UTILITY(U,$J,358.3,25226,1,2,0)

 +98      ;;=2^96156

 +99      ;;^UTILITY(U,$J,358.3,25226,1,3,0)

 +100     ;;=3^Hlth/Behav,Assess/Reassess,Ea 15 min

 +101     ;;^UTILITY(U,$J,358.3,25227,0)

 +102     ;;=96158^^91^1144^2^^^^1

 +103     ;;^UTILITY(U,$J,358.3,25227,1,0)

 +104     ;;=^358.31IA^3^2

 +105     ;;^UTILITY(U,$J,358.3,25227,1,2,0)

 +106     ;;=2^96158

 +107     ;;^UTILITY(U,$J,358.3,25227,1,3,0)

 +108     ;;=3^Hlth/Behav Interv,Indiv,Init 30 min

 +109     ;;^UTILITY(U,$J,358.3,25228,0)

 +110     ;;=96159^^91^1144^3^^^^1

 +111     ;;^UTILITY(U,$J,358.3,25228,1,0)

 +112     ;;=^358.31IA^3^2

 +113     ;;^UTILITY(U,$J,358.3,25228,1,2,0)

 +114     ;;=2^96159

 +115     ;;^UTILITY(U,$J,358.3,25228,1,3,0)

 +116     ;;=3^Hlth/Behav Interv,Indiv,Ea Addl 15 min

IBDEI1K2.m